Insulin Resistance Predicts 12 Cancer Types Early, Joint Research Finds

A groundbreaking collaborative study between Taiwan's Taichung Veterans General Hospital (TVGH) and Japan's University of Tokyo has unveiled a critical connection between insulin resistance and the heightened risk of developing at least 12 types of cancer. This significant finding, published in the prestigious journal 'Nature Communications,' offers a new frontier in cancer prevention, particularly highlighting the elevated risks for endometrial and kidney cancers. The research, spanning two and a half years, utilized TVGH's proprietary 'AI-IR' artificial intelligence tool to predict insulin resistance based on nine clinical parameters, subsequently analyzing its correlation with cancer and cardiovascular disease risks.

Dr. Chen Hsin-hua, Director of TVGH's Digital Medicine Department, explained that when the body exhibits insulin resistance, it compensates by secreting more insulin to manage blood sugar. This hormonal response can lead to increased fat accumulation, which in turn stimulates cell proliferation, including tumor cells. The study, which analyzed over 370,000 participants aged 40-69 across Europe, identified specific risk increases: kidney cancer (55.7%), esophageal cancer (46.4%), pancreatic cancer (29.1%), and breast cancer (13.5%), among others. This research provides crucial insights for both medical professionals and the public regarding metabolic health and cancer prevention strategies.

From a Taiwanese perspective, this collaboration underscores the nation's commitment to advancing medical research and international scientific cooperation. The development of the 'AI-IR' tool by a Taiwanese institution, coupled with its application in this significant study, highlights the country's growing capabilities in medical technology and data analysis. Dr. Chen's recommendations—emphasizing a high-fiber, plant-based diet, 2.5 hours of aerobic exercise weekly, and two days of strength training—offer practical, actionable advice for the public. This focus on lifestyle interventions, integrated with advanced predictive diagnostics, represents a holistic approach to health that resonates deeply within a society increasingly conscious of preventative care and well-being. The findings empower individuals to take proactive steps towards mitigating their cancer risk by addressing metabolic health.